AstraZeneca
-
Physical AI Multiply Labs Raises $75M in Series B Funding to Expand Robotic Drug Manufacturing
Insider Brief Multiply Labs raised $75 million in Series B funding to expand its robotic systems for automating manual steps in biologics manufacturing. According to the San Francisco-based startup, Dr. Patrick Soon-Shiong and NantWorks… -
Physical AI Multiply Labs Announces New Collaboration with AstraZeneca to Automate Cell Therapy Manufacturing with Robotics
-
Physical AI · Autonomous Driving AI Insider’s The Week Ahead: AstraZeneca Inks $5 Billion Dollar Research Deal, AMA Adopts AI Policy, AI-Generated Podcasts Good for Science, Plus AI Events from London to Singapore
-
Business & Markets · Enterprise AstraZeneca, Serving as a Model for Responsible Innovation in Patient Care with AI
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.